Fungal nail infection, medically known as Onychomycosis, is a common, often persistent condition that affects the nails of the toes and fingers. It can cause discoloration, thickening, separation of the nail plate, and sometimes pain or social embarrassment. (Ovid)
In this article, we explore the causes, risk factors, diagnosis, and modern treatment options for fungal nails — all grounded in recent literature and best-practice guidance.
What Is Fungal Nail (Onychomycosis)?
Onychomycosis refers to a fungal infection of the nail unit (nail plate, nail bed or nail matrix). (JAMA Network)
While it is not life-threatening, it is a public health issue because of its high prevalence, chronic nature, risk of recurrence and impact on quality of life. (PubMed)
Prevalence & Impact
- The estimated prevalence in adults in North America can be as high as ~13.8% according to family-practice review. (AAFP)
- Prevalence increases with age: in people over 60 or 70, risk is substantially higher. (PubMed)
- Beyond cosmetic issues, it can cause pain, impaired function (especially in the toes), psychological effects (embarrassment), and serve as a reservoir for other infections. (Lippincott Journals)
Causes & Risk Factors
Causative Organisms
- The majority of cases are caused by dermatophyte fungi, especially Trichophyton rubrum and Trichophyton mentagrophytes. (Dove Medical Press)
- Other causative organisms include yeasts (eg. Candida albicans) and non-dermatophyte molds (eg. Aspergillus spp.) — though less common. (Dove Medical Press)
- Mixed infections (more than one type of organism) complicate diagnosis and treatment. (AAFP)
Risk Factors
Key risk factors include:
- Age: Older adults face higher risk. (PubMed)
- Existing skin fungal infection: e.g., Tinea pedis (athlete’s foot) can lead to nail involvement. (JAMA Network)
- Nail trauma: Injury to the nail or repeated micro-trauma reduces defence. (JAMA Network)
- Immune compromise or comorbid conditions: E.g., diabetes, peripheral vascular disease, psoriasis, HIV, immunosuppressive therapy. (AAFP)
- Poor peripheral circulation: Especially relevant for toenails. (AAFP)
- Environment & habits: Sharing nail clippers, walking barefoot in communal areas, wearing occlusive footwear, poor foot hygiene. (Ovid)
- Other: Certain medications, smoking, family history.
Why It’s So Hard to Treat
- Nails grow slowly, especially toenails, which delays visible recovery. (PMC)
- The nail plate acts as a barrier to penetration of topical antifungals. (MDPI)
- Fungal spores may persist in footwear or surrounding skin, leading to relapse. (MDPI)
Diagnosis
Accurate diagnosis is essential before treatment because many nail problems (trauma, psoriasis, lichen planus) can mimic fungal nails. (PubMed)
Diagnostic methods:
- Clinical assessment: discoloration (yellow, white, brown), thickening, nail plate separation, crumbly debris. (Ovid)
- Laboratory confirmation:
- KOH (potassium hydroxide) preparation of nail scrapings. (AAFP)
- Fungal culture. (JAMA Network)
- Histologic staining (eg. Periodic acid-Schiff) for increased sensitivity. (PubMed)
- PCR and molecular techniques in research settings. (Karger Publishers)
Key points:
- Mis-diagnosis is common; blindly treating presumed fungal nails without confirmation reduces efficacy. (JAMA Network)
- It’s important to determine the type of organism (dermatophyte vs non-dermatophyte) because treatment response varies. (Karger Publishers)
Treatment Options (Based on Recent Literature)
Treatment selection should consider the severity of onychomycosis (number of nails involved, depth of infection), organism type, patient comorbidities, risk of side-effects, cost, and patient preference. (Dove Medical Press)
Oral (Systemic) Antifungals
- Systemic therapy remains the most effective for moderate-to-severe cases. (Ovid)
- Common agents:
- Considerations: potential side-effects (liver toxicity, drug interactions), longer duration, need for monitoring. (Ovid)
Topical Treatments
- Less systemic risk, but lower efficacy — best for mild or limited disease. (Ovid)
- Newer topical agents: e.g., 10% solutions, newer formulations under study. Example: The May 2025 RCT found a topical nail solution superior to placebo in pedal onychomycosis. (SpringerLink)
- Standard topical options: medicated nail lacquers, creams, paint-on solutions. (Lippincott Journals)
Combination & Procedural Therapies
- Nail debridement/trimming: reduces fungal load and helps medication penetration. (PubMed)
- Laser therapy, photodynamic therapy: evidence is emerging but not yet standard of care. A systematic review in 2024 explored laser vs other methods.
- Adjunctive treatments: 40% urea as nail-plate softener/enhancer of topical absorption. (Gulf Derma Journal)
- Proper footwear hygiene, foot care, treating co-existent athlete’s foot.
Recent Developments & Paradigm Shifts
- A “paradigm shift” article (2021) emphasises laboratory-directed treatment, identifying resistant organisms, and tailoring therapies rather than one-size-fits-all. (Karger Publishers)
- A 2025 RCT on a novel topical nail solution (Infectious Diseases & Therapy) suggests improved topical efficacy for pedal onychomycosis. (SpringerLink)
- Reviews note that relapse remains a major issue — 6.5% to 50+% in different studies. (MDPI)
Treatment Guidance: What to Do & When
- Assess severity
- Limited to one toenail? Mild involvement → consider topical therapy.
- Multiple nails, thick dystrophic changes, immunocompromised patient → systemic therapy likely needed.
- Confirm diagnosis (lab test) if feasible — avoids wasted treatment.
- Select therapy:
- Mild: topical + debridement + foot hygiene.
- Moderate/severe: systemic (eg. terbinafine) ± topical adjunct, debridement.
- Duration & monitoring
- Treat until new healthy nail growth is evident (can take many months). (PMC)
- Monitor for side-effects if using systemic.
- Prevent reinfection/relapse
- Good foot hygiene, rotate shoes, disinfect footwear and socks, treat other fungal infections (feet). (Ovid)
- Avoid risk factors (trauma, shared tools, walking barefoot in communal areas).
- Manage expectations
- Complete (clinical) cure may be challenging; improvement is realistic goal. (Lippincott Journals)
Prevention Tips
- Keep feet dry, change socks if sweaty.
- Avoid walking barefoot in public “wet” areas (eg. locker rooms, pools).
- Use breathable footwear.
- Don’t share nail clippers, files or shoes.
- Trim nails properly and promptly.
- Disinfect footwear and rotating pairs.
- Manage comorbid conditions (diabetes, vascular disease, etc).
Summary
Fungal nail infection (onychomycosis) is a common, persistent, and sometimes challenging condition to treat. Understanding the causes — the predominant role of dermatophytes, risk factors like age, trauma, immunosuppression — is key. Diagnosis should ideally be confirmed before extensive treatment. Treatment must be chosen based on severity, organism type, patient factors — with systemic antifungals still the most effective in many cases, and topical treatments or adjunct approaches for milder disease. Importantly, relapse prevention through hygiene and foot care is essential.
With recent developments (new topicals, laser options, lab-directed therapies), outcomes are improving — but patience and realistic expectations are required, as nail growth is slow and the barrier nature of the nail makes treatment inherently slower and less predictable than skin fungal infections.
This article is for informational purposes only and should not replace sound medical care from your podiatrist or other doctor.